Fig. 2From: Cancer metabolites: promising biomarkers for cancer liquid biopsyOverview of total contents. With the discovery of abnormal metabolites in cancer and the development of high-throughput metabolomics, circulating metabolites are expected to be potential biomarkers for early detection and diagnosis of cancer in the cotext of liquid biopsyBack to article page